J&J’s Bedaquiline: 10 Days Early For GAIN Incentive
This article was originally published in RPM Report
Executive Summary
Janssen Pharmaceuticals’ MDR-TB compound bedaquiline has the right indication to get an extra five years of exclusivity through the Generating Antibiotic Incentives Now Act – but the NDA was submitted too early to qualify.